3. Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur. Heart J. 2019;40:2671–83.
4. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2021;42:3599–726.
5. Rodriguez MML, Guerrero CJV, Garzon JCA, Marin DFHPAO, Avila AFS, Padilla JDV. Cardiogenic shock. Interv. Cardiol. 2019;11:123.
12. Lang CN, Kaier K, Zotzmann V, Stachon P, Pottgiesser T, von zur Muehlen C, et al. Cardiogenic shock: incidence, survival and mechanical circulatory support usage 2007–2017-insights from a national registry. Clin. Res. Cardiol. 2021;110:1421–30.
19. van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation 2017;136:e232–68.
22. Warren A, Rosner C, Gattani R, Truesdell A, Proudfoot A. Cardiogenic Shock: Protocols, Teams, Centers, and Networks. US Cardiol. Rev. 2021;15.
39. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI). Pedoman Tatalaksana Sindrom Koroner Akut. Edisi ketiga, tahun 2020.
40. Xanthopoulos A,Starling RC, Kitai T, Triposkiadis F. Heart Failure and Liver Disease: Cardiohepatic Interactions. JACC: Heart Failure. Vol 7, Issue 2, February 2019, p. 87-97.
41. Soares ROS, Losada DM, Jordani MC, Évora P, Castro-E-Silva O. Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies. Int J Mol Sci. 2019;20(20):5034. Published 2019 Oct 11. doi:10.3390/ijms20205034
42. Naito H, Nojima T, Fujisaki N, et al. Therapeutic strategies for ischemia reperfusion injury in emergency medicine. Acute Med Surg. 2020;7(1):e501. Published 2020 Apr 13. doi:10.1002/ams2.501
43. Jordan M, Caesar J. Improving door-to-needle times for patients presenting with ST-elevation myocardial infarction at a rural district general hospital. BMJ Qual Improv Rep. 2016;5(1):u209049.w6736. Published 2016 Dec 19. doi:10.1136/bmjquality.u209049.w6736
44. Reyentovich A. Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction. Wolters Kluwer, Uptodate. 2020.
45. Schumann J, Henrich EC, Strobl H, et al. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev. 2018;1(1):CD009669. Published 2018 Jan 29. doi:10.1002/14651858.CD009669.pub3
46. Avva U, Lata JM, Kiel J. Airway Management. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK470403/
47. Farmakis D, Agostoni P, Baholli L, Bautin A, Comin-Colet J, et al. A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus. International Journal of Cardiology 297 (2019) 83–90.
48. Shankar A, Gurumurthy G, Sridharan L, et al. A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock. Clin Med Insights Cardiol. 2022;16:11795468221075064. Published 2022 Feb 7. doi:10.1177/11795468221075064
49. Khan TM, Siddiqui AH. Intra-Aortic Balloon Pump. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK542233/
50. Tandukar S, Palevsky PM. Continuous Renal Replacement Therapy: Who, When, Why, and How. Chest. 2019;155(3):626-638. doi:10.1016/j.chest.2018.09.004